Michigan Marijuana Sales Top $234.5 Million in February, Price Per Ounce Down 10% From a Year Ago
- Michigan reported $234.5 million in total marijuana sales in February, with $234.17 million from adult-use and $386,903 from medical marijuana sales.
- February sales were about 3% lower than in February 2025, but average adult-use flower prices dropped nearly 10%, indicating continued strong consumer demand at lower prices.
- The adult-use marijuana market has generated nearly $13.86 billion in lifetime sales, with medical sales pushing the cumulative total even higher.
- As of February 28, Michigan had 930 licensed marijuana retailers and a total of 3,992 active marijuana business licenses statewide.
Michigan brought in $234.5 million in combined marijuana sales in February, according to a new report (PDF) released by the Cannabis Regulatory Agency. That included $234,170,098.28 in adult-use sales and $386,903.69 in medical marijuana sales. The February total is around 3% lower than the roughly $242 million sold in February 2025. Even so, the decline in revenue came as prices fell at a much sharper rate, with the average adult-use flower price dropping to $59.85 an ounce, down around 10% from a year earlier. That suggests consumers are still buying large amounts of marijuana, but at lower prices than they were paying this time last year.
Michigan’s adult-use market has now generated $13,856,734,077.98 in all-time sales. When medical sales are included, the long-term total is even higher, further underscoring the scale of the state’s legal marijuana industry.
State figures show there were 835 licensed adult-use retailers and 95 medical provisioning centers active as of February 28, giving Michigan a combined 930 licensed retailers. Overall, the state had 2,159 active adult-use licenses and 1,833 active medical licenses, for a combined total of 3,992 licensed marijuana businesses.
Adult-use flower remained the top-selling category in February at just over $100.2 million, followed by vape cartridges at $45.6 million and inhalable compound concentrates at $36.5 million. Infused edibles also continued to post strong numbers, generating nearly $19.8 million for the month.